Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis

NCT03478280 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT03478280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03478280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis
Lead sponsor
Aarhus University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
September 15, 2018
Completion date
March 15, 2020
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis